A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

November 22, 2021

Study Completion Date

November 22, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Marstacimab PFP

300 milligrams (mg) subcutaneous injection marstacimab PFP

DRUG

Marstacimab PFS

300 mg subcutaneous injection of marstacimab PFS

Trial Locations (1)

Brussels Clinical Research Unit, Brussels